Enzyvant Therapeutics, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$153Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
19clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Zamaneh Mikhak | Boston, MA | Pediatric Allergy/Immunology | $73,455.00 |
| Edwin Parsley | Houston, TX | Critical Care Medicine (Internal Medicine) | $60,450.00 |
| John Belperio | Los Angeles, CA | Pulmonary Disease | $10,000.00 |
| Jennifer Heimall | Philadelphia, PA | Pediatric Allergy/Immunology | $4,400.00 |
| Vivian Hernandez-Trujillo | Miami Lakes, FL | Pediatric Allergy/Immunology | $4,262.50 |
| Sarah Nicholas | Houston, TX | Allergy & Immunology (Internal Medicine) | $176.43 |
| Chanchaldeep Sood | Chapel Hill, NC | $58.81 | |
| Edith Schussler | New York, NY | Allergy & Immunology | $58.81 |
| Melissa Gans | Miami, FL | Pediatric Allergy/Immunology | $58.81 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.